Cornea/External Disease News

Today’s presbyopes lead increasingly digital lifestyles, with extensive attention to screens, which research shows can cause decreased and incomplete blinking, tear film instability and lead to the development of dry eye disease.

Prolonged periods of gaming may contribute to the development of dry eye symptoms in young adults, according to a study presented at the 2023 EastWest Eye Care Conference.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Renee Bovelle, MD, discusses real-world insights on the use of Dextenza.

Harrow announced an early completed transfer of the new drug application for Triesence, a synthetic corticosteroid for treatment of several inflammatory ophthalmic conditions, including those not responsive to topical corticosteroids.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Penny A. Asbell, MD, FACS, MBA, overviews the ARMOR study and antibiotic resistance in eye infections.

Oh my. Another FDA recall of generic artificial tears hit the news during eyeball month.

The FDA issued a complete response letter regarding the new drug application for reproxalap for the treatment of dry eye disease, according to a press release from Aldeyra Therapeutics.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, John Sheets, PhD, of Pantheon Vision, discusses the launch of the company and its goal of combatting corneal blindness globally.

In an interactive panel at the Twin Cities Ocular Surface Disease Symposium, speakers and attendees shared insight and experience with different treatment options and procedural techniques for patients with ocular surface disease.

Kilitch Healthcare India Limited has voluntarily recalled 25 over-the-counter eye drop products after the FDA warned of unsanitary conditions and potential safety concerns, according to a company press release.